combination therapy for neuroblastoma
A patient who is receiving combination therapy for neuroblastoma develops dysuria, hematuria and hemorrhage. Which is the likely drug to be used? Discuss in detail why and what are the treatment strategies?
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.